{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:28:00Z","timestamp":1789450080988,"version":"build-2803163510"},"reference-count":50,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Antibody specificities of pre- and postvaccination serum samples from 40 (53%) teenagers who received three doses of the Norwegian\n            <jats:italic>Neisseria meningitidis<\/jats:italic>\n            serogroup B vaccine (B:15:P1.7,16) during a previous trial in Iceland (Perkins et al., J. Infect. Dis.\n            <jats:bold>177:<\/jats:bold>\n            683-691, 1998) were analyzed with serum bactericidal activity (SBA) and immunoblotting assays with reference and isogenic meningococcal H44\/76 vaccine strains. The H44\/76 variants demonstrated significant vaccine-induced SBA to P1.7,16 PorA and Opc but not to PorB, Opa5.5, and a heterologous PorA protein. On blots, immunoglobulin G levels to all these proteins increased significantly after vaccination. Measurement of SBA to the two main variable regions (P1.7 and P1.16) on the P1.7,16 PorA with PorA deletion mutants revealed significantly higher activity to the P1.7,\u2212 and P1.\u2212,16 mutants compared to the P1.7,16 strain, indicating exposure of new accessible epitopes. Only 12 (30%) serum samples showed distinct decreases with these or the P1.\u2212,\u2212 mutant, with most samples containing SBA to the P1.7 and P1.16 combination. In contrast, P1.16-specific antibodies were mainly found on blots. Thirteen of the vaccinees (32.5%) were carriers of meningococci at the time of the third dose, of whom four (30.8%) harbored strains of the ET-5 complex. Carriage of P1.15 strains was generally reflected in \u22654-fold increases in SBA and distinct immunoglobulin G binding to the P1.19,15 PorA on blots. Although vaccination did not elicit bactericidal activity to the serotype 15 PorB, most carriers of serotype 15 strains showed \u22654-fold increases in SBA to this antigen.\n          <\/jats:p>","DOI":"10.1128\/iai.71.7.3775-3781.2003","type":"journal-article","created":{"date-parts":[[2003,6,21]],"date-time":"2003-06-21T16:09:13Z","timestamp":1056211753000},"page":"3775-3781","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine"],"prefix":"10.1128","volume":"71","author":[{"given":"Elisabeth","family":"Wedege","sequence":"first","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health, N-0403 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Kuipers","sequence":"additional","affiliation":[{"name":"Laboratory of Vaccine Research, The Netherlands Vaccine Institute, 3720 AL Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Bolstad","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health, N-0403 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"van Dijken","sequence":"additional","affiliation":[{"name":"Laboratory of Vaccine Research, The Netherlands Vaccine Institute, 3720 AL Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Oddvar","family":"Fr\u00f8holm","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health, N-0403 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementien","family":"Vermont","sequence":"additional","affiliation":[{"name":"Laboratory of Vaccine Research, The Netherlands Vaccine Institute, 3720 AL Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health, N-0403 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germie","family":"van den Dobbelsteen","sequence":"additional","affiliation":[{"name":"Laboratory of Vaccine Research, The Netherlands Vaccine Institute, 3720 AL Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2000.tb01519.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91961-S"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00037-N"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.4.867"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1099\/13500872-141-7-1593"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4360"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(94)90076-0"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1999.3144"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.5.2406-2413.1999"},{"key":"e_1_3_2_11_2","first-page":"504","year":"1985","unstructured":"Frasch, C. E., W. D. Zollinger, and J. T. Poolman. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis.7:504-510.","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_12_2","first-page":"67","volume":"14","year":"1991","unstructured":"Fredriksen, J. H., E. Rosenqvist, E. Wedege, K. Bryn, G. Bjune, L. O. Fr\u00f8holm, A. K. Lindbak, B. M\u00f8gster, E. Namork, U. Rye, G. Stabbetorp, R. Winsnes, B. Aase, and O. Closs. 1991. Production, characterization and control of MenB-Vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann.14:67-80.","journal-title":"NIPH Ann."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.11.4734-4742.1993"},{"key":"e_1_3_2_15_2","first-page":"147","volume":"14","year":"1991","unstructured":"H\u00f8iby, E. A., E. Rosenqvist, L. O. Fr\u00f8holm, G. Bjune, B. Feiring, H. N\u00f8kleby, and E. R\u00f8nnild. 1991. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann.14:147-156.","journal-title":"NIPH Ann."},{"key":"e_1_3_2_16_2","first-page":"186","volume":"9","year":"1978","unstructured":"Holten, E. 1978. Serotypes of Neisseria meningitidis isolated from patients in Norway during the fiarst six months of 1978. J. Clin. Microbiol.9:186-188.","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-43-5-335"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/515622"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Kuipers B. G. van den Dobbelsteen E. Wedege and L. van Alphen. 2001. Serological characterisation p. 131-145 In A. J. Pollard and M. C. J. Maiden (ed.) Meningococcal disease: methods in molecular medicine vol. 67. Humana Press Totowa N.J.","DOI":"10.1385\/1-59259-149-3:131"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1991.tb00743.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00047-5"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91297-8"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00324-8"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.10.4755-4761.1998"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2000.tb01493.x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.10.4419-4424.1994"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93086-3"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(96)00001-1"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/514232"},{"key":"e_1_3_2_30_2","first-page":"2","volume":"1995","year":"1995","unstructured":"Ristola, M., M. Jahkola, H. K\u00e4yhty, M. Sarvas, P. H. M\u00e4kel\u00e4, D. Caugant, and R. Visakorpi. 1995. Meningococcal outbreak in Southern Finland. Eur. Commun. Dis. Bull.1995:June2-3.","journal-title":"Eur. Commun. Dis. Bull."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.3.1301-1309.2002"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.5.1065"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1993.1070"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4642-4652.1995"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.7.2745-2751.1996"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.12.5184-5190.1997"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.5.3.348-354.1998"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(87)90059-3"},{"key":"e_1_3_2_39_2","first-page":"195","volume":"14","year":"1991","unstructured":"Sierra, G. V. G., H. C. Campa, N. M. Varacel., I. L. Garcia, P. L. Izquierdo, P. F. Sotolongo, G. V. Casanueva, C. O. Rico, C. R. Rodriguez, and M. H. Terry. 1991. Vaccines against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann.14:195-210.","journal-title":"NIPH Ann."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1971-1973.2001"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.16.1520"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.5.1355-1359.1990"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.molbev.a003991"},{"key":"e_1_3_2_44_2","first-page":"113","volume":"29","year":"1997","unstructured":"van den Elsen, J. M. H., J. N. Herron, P. Hoogerhout, J. T. Poolman, E. Boel, T. Logtenberg, J. Wilting, D. J. A. Crommelin, J. Kroon, and P. Gros. 1997. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in a complex with a fluorecein-conjugate peptide. Proteins29:113-125.","journal-title":"Proteins"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3223-3231.1998"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-31-3-195"},{"key":"e_1_3_2_47_2","first-page":"83","volume":"14","year":"1991","unstructured":"Wedege, E., G. Bjune, L. O. Fr\u00f8holm, E. A. H\u00f8iby, and E. Rosenqvist. 1991. Immunoblotting studies of vaccinee and patient serum samples from a Norwegian serogroup B meningococcal vaccination trial. NIPH Ann.14:83-186.","journal-title":"NIPH Ann."},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(00)00245-3"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(88)90381-X"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.8.4028-4034.2002"},{"key":"e_1_3_2_51_2","first-page":"37","volume":"85","year":"1991","unstructured":"Zollinger, W. D., and E. Moran. 1991. Meningococcal vaccines\u2014present and future. Trans. R. Soc. Trop. Med. Hyg.85(Suppl. 1):37-43.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.7.3775-3781.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.7.3775-3781.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T03:49:22Z","timestamp":1646452162000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.71.7.3775-3781.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1128\/IAI.71.7.3775-3781.2003"],"URL":"https:\/\/doi.org\/10.1128\/iai.71.7.3775-3781.2003","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"2002-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-03-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}